Health
CureVac Initiates Rolling Submission With European Medicines Agency for COVID-19 Vaccine Candidate, CVnCoV – Press Release – Digital Journal
Rolling submission with EMA initiated to accelerate time to potential marketing authorization of CVnCoV
- Rolling submission with EMA initiated to accelerate time to potential marketing authorization of CVnCoV
- Submission of CVnCoV pre-clinical data package marks start of the rolling process
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / February 12, 2021 / CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), today announced initiation of a rolling submission with the European Medicines Agency (EMA)…
Continue Reading
-
Noosa News15 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
Noosa News16 hours agoDepartment of Transport and Main Roads orders shutdown of North Ipswich Free Shop
-
General16 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
Noosa News19 hours agoFlawed government agreement opened door for unlawful site access